Global Companion Diagnostics Market 2014-2018: Licensing Agreements, Product Launches, Collaborations, Acquisitions, Capital Investment and Government Support to Bolster Industry
DUBLIN, Apr. 28, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/lwbs3b/global_companion) has announced the addition of the "Global Companion Diagnostics Market 2014-2018" report to their offering.
http://photos.prnewswire.com/prnh/20130307/600769
Companion diagnostics is used to identify suitable patients to whom specific drugs can be administered and it monitors the prognosis of the effects of the drug(s) on the disease. This concept of combining a drug with a diagnostic test is termed predictive medicine or personalized medicine. The companion diagnostic test has the ability to predict disease risk, diagnose disease, and monitor the therapeutic response. The tests enable physicians to make informed decisions on the type of drugs to use and the dosage in order to attempt to reduce the mortality rate of diseases such as cancer and neurodegenerative disorders.
The analysts forecast the Global Companion Diagnostics market will grow at a CAGR of 18.59 percent over the period 2013-2018.
This report covers the present scenario and the growth prospects of the Global Companion Diagnostics market for the period 2013-2018. To calculate the market size, the report considers revenue generated from the sales of companion diagnostic tests and associated kits provided by the vendors. It also presents the vendor landscape and a corresponding detailed analysis of key five vendors in the Global Companion Diagnostics market.
The market is highly fragmented, with the presence of many small and large vendors. It includes vendors that operate across the globe and have a substantial presence in North America and the European Union. In addition, the report discusses the major drivers that influence the growth of the Global Companion Diagnostics market. It also outlines the challenges faced by vendors and the market at large, as well as the key trends that are emerging in the market.
The report, the Global Companion Diagnostics Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Companion Diagnostics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Topics Covered:
1 Executive Summary
2 List of Abbreviations
3 Scope of the Report
4 Market Research Methodology
5 Introduction
6 Market Landscape
7 Geographical Segmentation
8 Buying Criteria
9 Market Growth Drivers
10 Drivers and their Impact
11 Market Challenges
12 Impact of Drivers and Challenges
13 Market Trends
14 Trends and their Impact
15 Vendor Landscape
16 Key Vendor Analysis
17 Other Reports in this Series
Companies Mentioned:
- 20/20 Genesystems Inc.
- A & G Pharmaceutical Inc.
- Abbott Laboratories
- AccuTheranostics Inc.
- Agilent Technologies Inc.
- Alacris Theranostics GmbH
- AutoGenomics Inc.
- Biogenex Laboratories Inc.
- LeicaBiosystems GmbH
- Life Technologies Inc.
- Luminex Corp.
- Qiagen N.V.
- Roche Holding AG
- Spartan Bioscience Inc.
- TheraDiag S.A.
- Theranostics Health Inc.
- Ventana Medical Systems Inc.
- bioMérieux SA
- pHLOGISTIX LLC
For more information visit http://www.researchandmarkets.com/research/lwbs3b/global_companion
Media Contact: Laura Wood, +353-1-481-1716, [email protected]
SOURCE Research and Markets
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article